A phase 1 study of ABT-806 in subjects with advanced solid tumors.
about
Toward the use of precision medicine for the treatment of head and neck squamous cell carcinomaHighly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies.Epidermal Growth Factor Receptor Cell Proliferation Signaling PathwaysEffects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates.Evaluation of the effect of the EGFR antibody-drug conjugate ABT-414 on QT interval prolongation in patients with advanced solid tumors likely to over-express EGFR.Antibody-Drug Conjugates (ADCs) for Personalized Treatment of Solid Tumors: A Review.Targeted therapies for targeted populations: Anti-EGFR treatment for EGFR amplified gastroesophageal adenocarcinoma.Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies.Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor.RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models
P2860
Q28074691-1CB9FC3B-6795-4527-9FEB-12F548519A83Q33721106-1F7EE649-5A9D-4576-82F3-BF56CF4D6EA4Q33737298-058DBC54-9102-4021-AF7F-845FD2010D3FQ38798481-6E1BE2DC-1819-4165-9DCB-43003FE1DD6EQ38872136-CA05C5D6-33B6-427F-8B97-B6DA802AE4D2Q39210427-59D8CDAB-8E21-49F7-A40B-3C1853601291Q49961144-E909670E-C201-4AF4-B13A-4A88F3E9D342Q50100856-6CC92143-7268-4CAC-B63E-10472F961AADQ52658297-9B831818-85FD-4835-BE41-7B5BE45E5268Q57493689-C73D1C42-4B29-4D73-B51F-000532FD9909
P2860
A phase 1 study of ABT-806 in subjects with advanced solid tumors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
A phase 1 study of ABT-806 in subjects with advanced solid tumors.
@en
A phase 1 study of ABT-806 in subjects with advanced solid tumors.
@nl
type
label
A phase 1 study of ABT-806 in subjects with advanced solid tumors.
@en
A phase 1 study of ABT-806 in subjects with advanced solid tumors.
@nl
prefLabel
A phase 1 study of ABT-806 in subjects with advanced solid tumors.
@en
A phase 1 study of ABT-806 in subjects with advanced solid tumors.
@nl
P2093
P2860
P1476
A phase 1 study of ABT-806 in subjects with advanced solid tumors.
@en
P2093
Edward B Reilly
Geoffrey I Shapiro
James M Cleary
Jorge Chaves
Kyle Holen
Matt Dudley
Michelle Pedersen
Nilofer Azad
Peter Ansell
P2860
P2888
P304
P356
10.1007/S10637-015-0234-6
P577
2015-04-17T00:00:00Z